Drug Database · Clinicians

Mecobalamin

Brands (21) Geocobalamin, Meconerv, Meconeuro…Show all

Vitamin B12 (cyanocobalamin and analogue); Hematinics; and others PH FDA category

Rx · Prescription drug28 PH productsPNF-listedVAT-exempt Kidney dosing reviewed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Contraindications

  • None listed in the retrieved insert
renalcarematters.com, reviewed

Dosing: Adult

  • Peripheral neuropathy (adults, oral): 1,500 micrograms/day in 3 divided doses
  • Amyotrophic lateral sclerosis (Japan, high-dose injection): 50 mg intramuscularly twice weekly (Rozebalamin; Japan-only indication)
renalcarematters.com, reviewed

Dosing: Altered kidney function

Mecobalamin (methylcobalamin) is an active vitamin B12 form, cleared mainly by the kidneys. The Japanese tablet insert does not address kidney impairment; a 2024 Japanese regulatory review of high-dose injection found only modest exposure increases with kidney impairment and concluded no dose adjustment is needed, with limited data in severe impairment. It has no US FDA drug label.

Kidney function measure: Japanese sources describe kidney impairment as mild, moderate or severe without dose changes; bands shown on creatinine clearance (CrCl).

Show full dosing details
CrCl ≥60 mL/min
Usual oral dose: 1,500 micrograms/day in 3 divided doses (500 micrograms three times daily); reassess if no effect after several months (PMDA insert).
CrCl 30–59 mL/min
No dose adjustment. A Japanese regulatory review of high-dose intramuscular mecobalamin (50 mg twice weekly) found AUC about 1.2-fold (mild, n=4) and 1.6-fold (moderate, n=3) versus a single normal subject; there are no PK data in severe impairment. PMDA concluded no dose adjustment is needed. Extrapolated to oral 1,500 micrograms/day (judgment); the oral tablet insert does not address kidney function.
CrCl 15–29 mL/min
No dose adjustment. A Japanese regulatory review of high-dose intramuscular mecobalamin (50 mg twice weekly) found AUC about 1.2-fold (mild, n=4) and 1.6-fold (moderate, n=3) versus a single normal subject; there are no PK data in severe impairment. PMDA concluded no dose adjustment is needed. Extrapolated to oral 1,500 micrograms/day (judgment); the oral tablet insert does not address kidney function.
CrCl <15 mL/min (not on dialysis)
No dose adjustment. A Japanese regulatory review of high-dose intramuscular mecobalamin (50 mg twice weekly) found AUC about 1.2-fold (mild, n=4) and 1.6-fold (moderate, n=3) versus a single normal subject; there are no PK data in severe impairment. PMDA concluded no dose adjustment is needed. Extrapolated to oral 1,500 micrograms/day (judgment); the oral tablet insert does not address kidney function.
Hemodialysis (intermittent)
No dialysis data in the Japanese sources.
Peritoneal dialysis
No dialysis data.
CRRT
No data.
  • Dialyzable? Not stated.
  • Monitoring Clinical response in peripheral neuropathy; do not continue for months without benefit (PMDA insert).
Children (kidney dosing)
eGFR ≥60
Not established in children; kidney dosing not applicable.
eGFR 30–59
Not established in children; kidney dosing not applicable.
eGFR 15–29
Not established in children; kidney dosing not applicable.
eGFR <15 (not on dialysis)
Not established in children; kidney dosing not applicable.
Hemodialysis (intermittent)
Not established in children; kidney dosing not applicable.
Peritoneal dialysis
Not established in children; kidney dosing not applicable.
CRRT
Not established in children; kidney dosing not applicable.

Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.

renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.

Source: PMDA (Japan) product information (October 2023). This generic has no US FDA label.

Dosing: Pediatric

Approved ages
No pediatric trials (PMDA insert).
Usual dose
Not established.

Kidney dosing in children: see Dosing: Altered kidney function.

renalcarematters.com, reviewed

Dosage forms

Philippines

  • Solution for injection: 500 mcg/mL
  • Film-coated tablet: 1 mg, 1.5 mg, 500 mcg
  • Capsule: 500 mcg
  • Sugar-coated tablet: 500 mcg
  • Chewable tablet: 500 mcg
  • Tablet: 500 mcg

Registered products in the Philippines

28 products registered with the Food and Drug Administration (FDA) Philippines list Mecobalamin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products28
Philippine FDA-registered products for Mecobalamin
Package insert
AdnervMecobalamin
500 mcg Chewable TabletAlu/Alu Blister Pack x 10's (Box of 60's)
RxVAT-exempt
Incepta Pharmaceuticals, Ltd.Bangladesh
Sahar International Trading, Inc.
DR-XY44776
Aug 26, 2028
GeocobalaminMecobalamin
500 mcg Sugar-Coated TabletAluminum/PVC Blister Pack x 10's (Box of 20's)
RxVAT-exempt
Geofman PharmaceuticalsPakistan
Sahar International Trading Inc.
DRP-7771
Mar 9, 2029
GeocobalaminMecobalamin
500 mcg/mL Solution For Injection (IM/IV)1 mL Amber Glass Ampoule Box of 10's
RxVAT-exempt
Geofman PharmaceuticalsPakistan
Sahar International Trading, Inc.
DRP-7803
Dec 29, 2029
IncobalMecobalamin
500 mcg/mL Solution For Injection (IM/IV)USP Type I Amber Glass Ampoule x 1 mL (Box of 10's)
RxVAT-exempt
Indus Pharma (Pvt.) Ltd.Pakistan
One Dexcel Pharma Inc.
DRP-13399
Feb 15, 2028
KalmecoMecobalamin
500 mcg CapsuleAluminum Foil Strip x 10's (Box of 100's)
RxVAT-exempt
PT. Kalbe Farma TbkIndonesia
Globo Asiatico Enterprises, Inc.
DR-XY49140
Jul 31, 2029
KeercominMecobalamin
500 mcg/mL Solution for Injection (IM/IV)USP Type I Amber Glass Ampoule x 1 mL (Box of 10 ampoules in transparent plastic tray)
RxVAT-exempt
Cooper Pharma LimitedIndia
L'Keeran EnterprisesImporter: Ambica International Corporation
DRP-10650-01
Aug 6, 2037
MaxibalMecobalamin
500 mcg/mL Solution for Injection (I.M./I.V.)Type I Amber Glass Ampoule in PVC Tray x 1 mL (Box of 10's)
RxVAT-exempt
Maxitech Pharma (Pvt) Ltd.Pakistan
Access Point International Trading Inc.Importer: Accesspoint International Trading, Inc.
DRP-15397
Jul 2, 2029
ME12Mecobalamin
500 mcg/mL Solution for Injection (IM/IV)Type I Amber Color Glass Ampoule x 1 mL (net content) Box of 10’S
RxVAT-exempt
CSPC Ouyi Pharmaceutical Co. Ltd.China
Medhart Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-8612
Aug 13, 2029
Mebaal-1500Mecobalamin
1.5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Windlas Biotech Limited (Plant-IV)India
Metro Drug, Inc.Trader: Mega Lifesciences (Australia) Pty. Ltd.
DR-XY38969
Mar 19, 2030
Mebaal-500Mecobalamin
500 mcg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Windlas Biotech Limited (Plant-IV)India
Metro Drug, Inc.Importer: Mega Lifesciences Limited Inc.Trader: Mega Lifesciences Limited Inc. (Australia) Pty. Ldt.
DR-XY37578
Mar 19, 2030
MecobalzoneMecobalamin
500 mcg Sugar-Coated TabletAluminum/PVC Blister Pack x 10's (Box of 20's)
RxVAT-exempt
Geofman PharmaceuticalsPakistan
Amson PharmaceuticalsImporter: Sahar International Trading, Inc.
DRP-7771-01
Mar 9, 2029
MeconervMecobalamin
1 mg Film-Coated TabletAlu-amber PVC/PVDC blister pack x 10's (Box of 3 blister packs x 10 tablets)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Phils., Inc.
DR-XY48322
Aug 30, 2027
MeconervMecobalamin
1.5 mg Film-Coated TabletAlu-Amber PVC/PVDC Blister Pack x 10's (Box of 3 blister packs x 10 tablets)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Phils., Inc.
DR-XY48321
Aug 30, 2027
MeconeuroMecobalamin
500 mcg CapsulePVC/PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
—
Prosweal Healthcare Inc.
DR-XY45800
Mar 3, 2027
MeconeuroMecobalamin
500mcg/mL Solution for Injection (IM/IV)1ml USP Type I amber glass ampoule mounted in PVC tray x 5 ampoules Box of 10 ampoules
RxVAT-exempt
PT. Novell Pharmaceutical LaboratoriesIndonesia
Prosweal Healthcare Inc.
DRP-7352
Sep 29, 2027
Mefredzil-1500Mecobalamin
500 mcg/mL Solution for Injection (IM/IV)USP Type I Amber Glass Ampoule x 3mL (Box of 10 ampoules in transparent plastic tray)
RxVAT-exempt
Cooper Pharma LimitedIndia
Ambica International Corporation
DRP-10649
May 20, 2027
Mefredzil-500Mecobalamin
500 mcg/mL Solution for Injection (IM/IV)USP Type I Amber Glass Ampoule x 1 mL (Box of 10 ampoules in transparent plastic tray)
RxVAT-exempt
Cooper Pharma LimitedIndia
Ambica International Corporation
DRP-10650
Nov 11, 2030
MethycobalMecobalamin
500 mcg TabletAlu/Red PVC Blister Pack x l0's (10 Blister Packs containing 100 tablets overwrapped in Aluminum Sachet per Box)
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
Zuellig Pharma Corp.Trader: Hi-Eisai Pharmaceutical Inc.
DR-XY14117
Nov 18, 2027
MethycobalMecobalamin
500mcg/mL Solution for Injection (IM/IV)Amber Glass Ampoule x 1 mL (Box of 10)
RxVAT-exempt
Nipro Pharma Corporation (Ise Plant)Japan
Zuellig Pharma CorporationImporter: Hi-Eisai Pharmaceutical Inc.
DR-XY7408
Apr 11, 2032
MineMecobalamin
500 mcg/mL Solution for Injection (I.M./I.V.)USP Type I amber glass ampoule x 1 mL (net content) (Box of 10's)
RxVAT-exempt
Bio-Labs (Pvt) Ltd.Pakistan
Nueva Sunshine Phils., Inc.
DRP-8457
Oct 10, 2029
NerveeminMecobalamin
500 mcg/mL Solution for Injection (IM/IV)1 mL Amber Glass Ampoule (Box of 10's)
RxVAT-exempt
Geofman PharmaceuticalsPakistan
Amson Pharmaceuticals
DRP-7803-02
Dec 29, 2029
NeurometMecobalamin
500 mcg CapsuleAluminum PVC blister pack x 10’s Box of 100’s
RxVAT-exempt
SAMCHUDANG PHARM. CO., LTDRepublic of Korea
D&G PHARMAImporter: UNIMEX, INC.
DR-XY36897
Nov 9, 2027
NoneMecobalamin
500 mcg/ mL Solution for Injection (IM/IV)USP Type I amber glass ampoule x 1 mL (net content) in Alu/PVC blister tray (Box of 4's)
RxVAT-exempt
Mankind Pharma Limited (Unit-1)India
I.E. Medica Inc
DRP-8506
Oct 22, 2029
NoneMecobalamin
500 mcg/mL Solution for Injection (IM/IV)Amber glass ampoule x 1 mL (Box of 5 ampoules in plastic tray)
RxVAT-exempt
Zee Laboratories LimitedHimachal Pradesh India
Eon Pharmatek Inc.
DR-XY48364
Sep 28, 2032
NurokindMecobalamin
500 mcg/ml Solution for Injection (IM/IV)USP Type I Amber Glass Ampoule x 1 mL (net content) in Alu/PVC Blister Tray (Box of 4's)
RxVAT-exempt
Mankind Pharma Limited (Unit-1)India
I.E. Medica, Inc.
DRP-8505
Oct 22, 2029
PhilaminMecobalamin
500 mcg/mL Solution for Injection (IM/IV)Type I Amber Color Glass Ampoule x 1 mL (net content) Box of 10's
RxVAT-exempt
CSPC Ouyi Pharmaceutical Co., LtdChina
PhilRx Pharma Inc.Importer: AMB HK ENTERPRISES INC.
DRP-8612-01
Aug 13, 2029
ZecobalMecobalamin
500 mcg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
The Schazoo Pharmaceutical Laboratories (Pvt) LtdPakistan
ZUNECA INCORPORATED
DR-XY43935
Dec 2, 2029
(no brand name)Mecobalamin
500 mcg/mL Solution for Injection (IM/IV)Type I Amber colored Glass Ampoule x 1 mL (Box of 10's)
RxVAT-exempt
Ta Fong Pharmaceutical Co., Ltd.Taiwan
Kwanstar Pharma DistributorTrader: Kwanstar Co., Ltd.
DRP-13386
Feb 9, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Adverse reactions

Common

  • Anorexia, nausea, vomiting, diarrhea (frequency unknown)
  • Rash

Serious

  • None specific listed in the retrieved insert
renalcarematters.com, reviewed

Monitoring parameters

  • Clinical response in peripheral neuropathy; do not continue for months without benefit (PMDA insert). Kidney
  • Clinical response
renalcarematters.com, reviewed

Pharmacokinetics

Key PK parameters

Time to peakIM 50 mg: about 1 to 2 hours
Half-lifeIM 50 mg: about 2.8 to 3.4 hours
Half-life in kidney failure (ESKD) kidneyAUC 6.78 (normal, n=1), 8.29 (mild) and 10.60 µg·h/mL (moderate) after IM 50 mg
Renal excretion kidneyMainly renal (animal data: about 92% to 99% in urine)
Dialyzability kidneyNot stated
renalcarematters.com, reviewed

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Mecobalamin 500 mcg Tablet₱10.00–₱13.67Reference ₱11.00per tabletDPRI procurement range
Mecobalamin 500 mcg/mL, 1 mL Ampule₱98.00–₱186.00Reference ₱173.00per ampuleDPRI procurement range

Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Mecobalamin
PNF listingOral: 500 microgram tablet
PNF listingInj.: 500 micrograms/mL, 1 mL ampul (IM, IV)
PhilHealth GAMOTNo

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Pharmaceuticals and Medical Devices Agency (Japan). Mecobalamin tablets 500 µg "TCK" package insert; Rozebalamin review report [PMDA (Japan) product information, October 2023; no US FDA label]. https://www.pmda.go.jp/PmdaSearch/bookSearch/01/04987124904116
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  4. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
  5. Tatsumi Chemical Co., Ltd. (2023). Mecobalamin tablets 500 µg "TCK" [Japanese package insert; revised October 2023]. Pharmaceuticals and Medical Devices Agency (PMDA), Japan. https://www.pmda.go.jp/PmdaSearch/bookSearch/01/04987124904116
  6. Pharmaceuticals and Medical Devices Agency. (2024). Review report: Rozebalamin for injection 25 mg (mecobalamin), Eisai Co., Ltd. [Report dated August 8, 2024]. https://www.pmda.go.jp/files/000277177.pdf

renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .